The questions most often asked about this emerging field of science, drug development, laboratory medicine and medical practice are:
1) When will pharmacogenomics really be used in the practice of medicine?
2) How will pharmacogenomics make the most significant changes in adverse drug reactions?
3) What drugs being prescribed today should be done only in conjunction with genotyping patients before treatment?
4) How will doctors be educated about this so they can decide if they should be offering this to their patients?
5) Who will pay for these tests? Are they reimbursed by insurers?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment